Advisor Group Holdings, Inc. Vigil Neuroscience, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.1 Billion
- Q1 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 501 shares of VIGL stock, worth $961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
501Holding current value
$961% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
57Shares Held
28.8MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$11.2 Million1.62% of portfolio
-
Northpond Ventures, LLC4.21MShares$8.09 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$3.82 Million0.15% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$3.48 Million0.11% of portfolio
-
Abrdn PLC1.72MShares$3.31 Million0.01% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $54.3M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...